| 000 | 00410nam a2200133Ia 4500 | ||
|---|---|---|---|
| 008 | 170516s9999 xx 000 0 und d | ||
| 245 | 2 | _aA Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab | |
| 260 | _bTheranostics | ||
| 260 | _c2015 | ||
| 300 | _a5:8 | ||
| 650 | _xMedical Technology | ||
| 650 | _xMedtech | ||
| 856 | _uhttp://www.thno.org/v5i8 | ||
| 999 |
_c329946 _d329946 |
||